Nishith Desai’s animal healthcare player SeQuent bought by AZB’s Carlyle for $209m

Posted on By Legal 60

The US based private equity firm The Carlyle Group has agreed to acquire 74% stake in SeQuent Scientific Limited, the largest pure-play animal healthcare company in India, for $210 million (Rs.1587 crore), company said on Friday. Carlyle will buy shares at a price of Rs.86 apiece.

— The Economic Times

Nishith Desai Associates advised SeQuent and the promoters of Sequent, including Arun Kumar and family with M&A co-head and leaderSimone Reis, leaderShreyas Bhushan and senior lawyerAmudavalli Kannan.

AZB & Partners partnerSayak Maity acted for Carlyle.

White & Case also acted for Carlyle.

2020-05-08

Deal value: $210m (Rs 1,580 crore)

This deal report is based on a firm’s press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

Click here if you are working with a law firm that has not been credited for this deal, and we will update the report promptly.

Read More